Labetuzumab govitecan (ADC)
Produktgrößen
1 mg
£1772,00
DHC21097-1MG
5 mg
£6137,00
DHC21097-5MG
Über dieses Produkt
- SKU:
- DHC21097
- Zusätzliche Namen:
- IMMU130, hMN-14-SN-38
- translate.label.attr.clone:
- Labetuzumab govitecan
- Klonalität:
- Monoclonal, Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Labetuzumab govitecan is an ADC consisting of a CEACAM5-directed antibody and SN38 used for the study of various cancers including colorectal cancer.
- Immunogen:
- CEACAM5
- Physischer Zustand:
- Liquid
- Reinheit:
- >90% as determined by sec.
- Aufreinigung:
- Ion Exchange
- Reaktivitäten:
- Human
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- -20[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- AntibodySystem
- Typ:
- Antibody: Recombinant Antibodies